Digital Health Today 360 with Dan Kendall Dan Kendall / Part of the Health Podcast Network

Guest host Sophie Park interviews health economist Jane Sarasohn-Kahn for this fast-paced discussion about women's health, social determinants of health and the 'she-cession' in the wake of the COVID-19 pandemic.
We've seen the headlines during COVID-19: Rising caseloads. Millions of lives lost. Economic devastation. Schools closed.
But these only tell part of the story.
The impact of the pandemic on mental and physical health extends far beyond those that are directly infected with the disease.
Delayed diagnosis, canceled or delayed treatment, loss of employment and the collision of home and professional responsibilities has had a tremendous and long-lasting impact.
Join Jane Sarasohn-Kahn and guest host Sophie Park in this discussion about the affects of the pandemic.
For more discussion about women's health, check out the video panel with Jane and Sonia Millsom, Chief Commercial Officer of Maven Clinic, on the September 9 Digital Health Forum.

Episode Links and Resources:

Connect with Jane Sarasohn-Kahn: Website | Twitter | LinkedIn |

Attend Digital Health Forum: Website | LinkedIn | Twitter


Tune into Episode 16 with Kate Ryder, founder of Maven Clinic


Guest Host Links


Twitter @sophiemariepark


Linkedin: https://www.linkedin.com/in/sophiemariepark/


Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Roche

Takeda

Every day, tech companies and governments frame the conversation around the use of data. With the proliferation of smartphones and wearable devices, online shopping, and home voice assistants, we leave a digital footprint with almost everything we do.
While our data can be crunched to drive better insights on listening habits, activity levels, and consumer preferences. There's also a far more important application for our data: to improve human lives and health outcomes. 
In this coffee talk, we explore how leaders in the pharmaceutical industry are working with people, policy makers and providers to create solutions that will usher in a new era of healthcare solutions and services.
This Coffee Talk is created with support from Takeda.
Guest Links and Resources:

Connect with Meni Styliadou: LinkedIn


Connect with Takeda: Website | Twitter | LinkedIn


Connect with H2O: Website | Twitter | LinkedIn | YouTube


European Patient Forum: Website


Innovative Medicines Initiative: Website | Twitter | LinkedIn | YouTube



Host Links
Connect with Dan: Twitter | LinkedIn


Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services.
Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care.
One of those organizations is Bayer.
In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy.

This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases.  
The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today.
The deadline to apply is June 20, 2021.

Guest Links and Resources:

Connect with Dom Kennerson: Twitter | LinkedIn


Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube


World Health Organization - Website | Constitution



Host Links
Connect with Dan: Twitter | Linkedin


Connect on Digital Health Today:
Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Dr. David E Albert is a physician, engineer, inventor and serial entrepreneur, and he's the founder and Chief Medical Officer of Alivecor. Dr. Albert has developed life-saving technologies and products for more than 30 years, and he's turned a number of those inventions into tech startups, even before it was a trendy thing to do.
Each year, over 20,000 students enrolled in medical schools across the US.
Over 600,000 businesses are started each year in the US, and nearly half fail within five years; two-thirds fail within 10 years.
So why do people who are on a path to a successful career in medicine decide to become entrepreneurs?
Dr. Albert says that "a lot of people go into medicine because it's not very risky. And so there's a real juxtaposition between those people who go into medicine because it's a secure professional lifestyle, and being an entrepreneur."
Back in January, 2011, Dr. Albert posted a four minute YouTube video showing how to turn an apple iPhone 4 into a wireless clinical quality cardiac event recorder. It's called AliveCor, and it looked like magic. Ten years later, the AliveCor company continues to grow and expand.
Tune into this special episode as we highlight the twists of fate and deliberate decisions that shaped Dr. Albert's career, and hear how his work and companies continue to make a lasting impact in the delivery of care.

Guest Links and Resources:

Connect with Dr. Dave Albert: Twitter | LinkedIn |

Connect with AliveCor: Website | Twitter | LinkedIn | YouTube


Dr. Albert's 2011 YouTube video showing the AliveCor ECG



Host Links


Twitter @healthtechdan


Linkedin: https://www.linkedin.com/in/dankendall/


Connect on Digital Health Today:
Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Cedars-Sinai Accelerator

Roche

Takeda

In this episode, we dive into a topic that is very close to my heart: improving the lives of people with diabetes.

You've certainly heard Kodak mentioned as a good example of how companies should *not* manage product development. A company that was once a household name is now known for missing out on the move to digital cameras.

For as long as businesses have existed, there have been companies that didn't move with the times - and we're not just talking about steam trains and pocket watches. There are thousands of case studies from the modern era that can teach important business lessons; lessons about things we should do, and lessons about things we shouldn't.

As the number of people with diabetes continues to climb globally, we see businesses working hard to adapt to the new and changing expectations of providers, employers and patients. Increasingly in healthcare, the innovation isn't just about a new technology or innovation. It's about creating sustainable business models that engage stakeholders across the value chain.

To understand more about the internal and external factors and decisions that drive innovation, I invited Adam Berman to the show. Adam is Director of Franchise Marketing at Roche Diabetes Care. He has over 15 years of experience in marketing and business leadership primarily in the diabetes category. 

Tune in as we explore diabetes as a use-case for taking bold steps to deliver better outcomes and experiences. We explore the capabilities of new digital solutions that Roche has developed, and the decisions that have enabled their development.

Note: Although Roche is a sponsor of the Digital Health Today platform, this episode is not a sponsored episode. I asked to interview Adam purely based on my professional and personal interests in gaining a better understanding of how Roche is driving digital solutions for better care, and to discuss what companies can and should do to succeed.

Hope you enjoy it. ~ Dan

Guest's Links and Resources:

Connect with Adam Berman: LinkedIn


Roche Diabetes Care Platform


Roche Diabetes Health Connection 


Sulli the Diabetes Guru - Alexa Skill for managing diabetes

MySugr


Host Links


Twitter @healthtechdan


Linkedin: https://www.linkedin.com/in/dankendall/


Connect on Digital Health Today:
Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Cedars-Sinai Accelerator

Roche

Takeda

"In this episode, I'm excited to introduce you to yet another outstanding health innovation leader who is hosting another new show on Digital Health Today. His degrees are in engineering and business, and he is a writer, entrepreneur, investor, and advisor. He is a truly multi-talented person and I'm pleased to also call him a friend. I'm honored to introduce the host of the new Asia Pacific Edition of Digital Health Today, Tony Estrella."
~ Dan Kendall, Founder of Digital Health Today

Click here to read the transcript

Links and Resources:

Connect with Tony Estrella: Twitter | LinkedIn | Personal Website


Connect with Taliossa



Read Tony's Book: Comatose


FutureProofing Healthcare

Full Whitepaper, Summary and Video: A Vision for Asia Pacific in 2050


Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Special thanks to:

Bayer G4A

Cedars-Sinai Accelerator

Takeda

Roche